Literature DB >> 10917157

Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection.

H Kimura1, K Nishikawa, Y Hoshino, A Sofue, Y Nishiyama, T Morishima.   

Abstract

Primary Epstein-Barr virus (EBV) infection in childhood is usually asymptomatic, but sometimes causes infectious mononucleosis (IM). Very occasionally, IM develops into a life-threatening EBV-associated hemophagocytic syndrome (EBV-AHS). We studied the importance and usefulness of measuring cell-free viral DNA in the serum of patients with these primary EBV infections. Using real-time quantitative polymerase chain reaction, cell-free EBV-DNA was quantified in the serum of nine children with IM and three with EBV-AHS. In the acute phase of IM, an average of 10(2.4) copies/ml of EBV-DNA was detected in 95% of sera. The EBV load gradually decreased and disappeared within 1 month. Patients with EBV-AHS had an extremely high viral load in their sera (10(5.5)-10(7.4) copies/ ml). The viral load persisted longer in these patients, although it decreased in parallel with the improvement of symptoms. These results indicate that cell-free EBV-DNA was frequently detected in patients with primary EBV infection and could, therefore, be used as a marker for EBV infection. Measuring the cell-free EBV-DNA is useful for monitoring the primary EBV infection, especially in EBV-AHS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10917157     DOI: 10.1007/s004300050006

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  7 in total

1.  Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Toru Takahashi; Eiichi Oeda; Yutaka Sato; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

2.  Real-time Epstein-Barr virus PCR for the diagnosis of primary EBV infections and EBV reactivation.

Authors:  Rianne Luderer; Marieke Kok; Hubert G M Niesters; Rob Schuurman; Okke de Weerdt; Steven F T Thijsen
Journal:  Mol Diagn       Date:  2005

Review 3.  Serological diagnosis of Epstein-Barr virus infection: Problems and solutions.

Authors:  Massimo De Paschale; Pierangelo Clerici
Journal:  World J Virol       Date:  2012-02-12

4.  Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Authors:  Christos Stefanou; Christiana Tzortzi; Fotini Georgiou; Chrystalla Timiliotou
Journal:  BMJ Case Rep       Date:  2016-12-09

5.  Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis.

Authors:  Hal B. Jenson
Journal:  Curr Infect Dis Rep       Date:  2004-06       Impact factor: 3.725

6.  HSV-2-related hemophagocytic lymphohistiocytosis in a fingolimod-treated patient with MS.

Authors:  Kazuhiro Ikumi; Tetsuo Ando; Harutaka Katano; Masahisa Katsuno; Yu Sakai; Mari Yoshida; Takahiko Saida; Hiroshi Kimura; Gen Sobue
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-06-07

Review 7.  Viral infections associated with haemophagocytic syndrome.

Authors:  Nadine Rouphael Maakaroun; Abeer Moanna; Jesse T Jacob; Helmut Albrecht
Journal:  Rev Med Virol       Date:  2010-03       Impact factor: 6.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.